论文部分内容阅读
目的探讨阿奇霉素与痰热清联合应用于小儿肺炎支原体肺炎临床治疗中的效果。方法选取本院在2009年12月至2012年6月收治的97例小儿肺炎支原体肺炎患儿的资料,将其按照住院号尾号的奇偶分为治疗组和对照组,其中治疗组49例患儿采用阿奇霉素与痰热清联合治疗,连续用药14d,对照组48例患儿采用阿奇霉素序贯治疗,观察比较两组患者的临床效果。结果治疗组患者有效率为97.96%,对照组有效率为83.33%,治疗组明显优于对照组患者;治疗组患者在咳嗽、发热以及肺部啰音消失时间均明显短于对照组患者;对照组毒副作用发生率为6.25%,治疗组为2.04%,两组比较差异性不大,无统计学意义。结论阿奇霉素与痰热清联合用药,可显著改善小儿肺炎支原体肺炎患儿的临床症状,提高治疗效果,值得推广。
Objective To investigate the effect of azithromycin combined with Tanreqing on the clinical treatment of Mycoplasma pneumoniae pneumonia in children. Methods The data of 97 cases of children with mycoplasma pneumoniae pneumonia admitted in our hospital from December 2009 to June 2012 were selected and divided into treatment group and control group according to the odd number of end number of hospitalization, in which 49 patients Children with azithromycin and Tanreqing combined treatment, continuous medication 14d, control group of 48 patients with azithromycin sequential treatment, observed and compared the clinical effect of two groups of patients. Results The effective rate of the treatment group was 97.96%, the effective rate of the control group was 83.33%, the treatment group was significantly better than the control group; the treatment group was significantly shorter than the control group in the cough, fever and pulmonary rales disappeared; The incidence of side effects was 6.25% in the treatment group and 2.04% in the treatment group. There was no significant difference between the two groups with no statistical significance. Conclusion Azithromycin combined with Tanreqing can significantly improve the clinical symptoms of children with Mycoplasma pneumoniae pneumonia, improve the therapeutic effect, it is worth promoting.